Momenta Pharmaceuticals, Inc. (MNTA)

[pollyvonwog]

WPIs 10% of the market approach is certainly curious. I've also heard that Sanofi has been unexpectedly ultra aggressive with pricing, which may be contributing to WPI not wanting to go to far in the retail (not sure I buy that reasoning). But I certainly think the wait and see theory holds water.

I also know that WPI is doing as little as possible with regards to lovenox. They've been very hands-off thus far.

Also, WPI seems pretty confident they would not be liable for any damages per their contract with Ampha. Is that confidence unfounded as clearly if MNTA did win the patent trial, Ampha would not be able to pay. I guess I'm not exactly sure as to how the courts would go after WPI.....

Also, what the heck happened to that $200m in product that was "about to expire"??!?